http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100050198-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2008-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f2dd388ff1e191ed66516b3fe993a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d3f410bf4fd6effd89e27837b1b0378 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4d946af56f0ea6c3df088e1c2e100ef |
| publicationDate | 2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100050198-A |
| titleOfInvention | Pharmaceutical composition for the treatment of immune diseases and cancer |
| abstract | The present invention relates to a pharmaceutical composition containing the fusion protein as an active ingredient, and more particularly, to a pharmaceutical composition useful for the treatment of immune diseases and cancer containing the Tat-ref-1 fusion protein of SEQ ID NO: 1 as an active ingredient. will be.n n n Pharmaceutical compositions containing the Tat-ret-1 fusion protein of the present invention as an effective ingredient can be effectively used for the prevention and treatment of immune diseases, autoimmune diseases and cancers related to the expression of HMGB1 by effectively inhibiting the expression of HMGB1. . |
| priorityDate | 2008-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 410.